1 Introduction to Research & Analysis Reports
1.1 Peptides Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 China Peptides Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 China Peptides Overall Market Size
2.1 China Peptides Market Size: 2021 VS 2027
2.2 China Peptides Revenue, Prospects & Forecasts: 2016-2027
2.3 China Peptides Sales: 2016-2027
3 Company Landscape
3.1 Top Peptides Players in China Market
3.2 Top China Peptides Companies Ranked by Revenue
3.3 China Peptides Revenue by Companies
3.4 China Peptides Sales by Companies
3.5 China Peptides Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Peptides Companies in China Market, by Revenue in 2020
3.7 Manufacturers Peptides Product Type
3.8 Tier 1, Tier 2 and Tier 3 Peptides Players in China Market
3.8.1 List of Tier 1 Peptides Companies in China
3.8.2 List of Tier 2 and Tier 3 Peptides Companies in China
4 Sights by Type
4.1 Overview
4.1.1 By Type - China Peptides Market Size Markets, 2021 & 2027
4.1.2 Insulin
4.1.3 Teriparatide
4.1.4 Liraglutide
4.1.5 Leuprolide
4.2 By Type - China Peptides Revenue & Forecasts
4.2.1 By Type - China Peptides Revenue, 2016-2021
4.2.2 By Type - China Peptides Revenue, 2022-2027
4.2.3 By Type - China Peptides Revenue Market Share, 2016-2027
4.3 By Type - China Peptides Sales & Forecasts
4.3.1 By Type - China Peptides Sales, 2016-2021
4.3.2 By Type - China Peptides Sales, 2022-2027
4.3.3 By Type - China Peptides Sales Market Share, 2016-2027
4.4 By Type - China Peptides Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - China Peptides Market Size, 2021 & 2027
5.1.2 Diabetes
5.1.3 Infectious Diseases
5.1.4 Cancer
5.1.5 Osteoporosis
5.2 By Application - China Peptides Revenue & Forecasts
5.2.1 By Application - China Peptides Revenue, 2016-2021
5.2.2 By Application - China Peptides Revenue, 2022-2027
5.2.3 By Application - China Peptides Revenue Market Share, 2016-2027
5.3 By Application - China Peptides Sales & Forecasts
5.3.1 By Application - China Peptides Sales, 2016-2021
5.3.2 By Application - China Peptides Sales, 2022-2027
5.3.3 By Application - China Peptides Sales Market Share, 2016-2027
5.4 By Application - China Peptides Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 Cipla Ltd.
6.1.1 Cipla Ltd. Corporation Information
6.1.2 Cipla Ltd. Overview
6.1.3 Cipla Ltd. Peptides Sales and Revenue in China Market (2016-2021)
6.1.4 Cipla Ltd. Peptides Product Description
6.1.5 Cipla Ltd. Recent Developments
6.2 Emcure Pharmaceuticals Pvt. Ltd.
6.2.1 Emcure Pharmaceuticals Pvt. Ltd. Corporation Information
6.2.2 Emcure Pharmaceuticals Pvt. Ltd. Overview
6.2.3 Emcure Pharmaceuticals Pvt. Ltd. Peptides Sales and Revenue in China Market (2016-2021)
6.2.4 Emcure Pharmaceuticals Pvt. Ltd. Peptides Product Description
6.2.5 Emcure Pharmaceuticals Pvt. Ltd. Recent Developments
6.3 Gland Pharma Limited
6.3.1 Gland Pharma Limited Corporation Information
6.3.2 Gland Pharma Limited Overview
6.3.3 Gland Pharma Limited Peptides Sales and Revenue in China Market (2016-2021)
6.3.4 Gland Pharma Limited Peptides Product Description
6.3.5 Gland Pharma Limited Recent Developments
6.4 Troikaa Pharmaceuticals Ltd.
6.4.1 Troikaa Pharmaceuticals Ltd. Corporation Information
6.4.2 Troikaa Pharmaceuticals Ltd. Overview
6.4.3 Troikaa Pharmaceuticals Ltd. Peptides Sales and Revenue in China Market (2016-2021)
6.4.4 Troikaa Pharmaceuticals Ltd. Peptides Product Description
6.4.5 Troikaa Pharmaceuticals Ltd. Recent Developments
6.5 Biological E Limited
6.5.1 Biological E Limited Corporation Information
6.5.2 Biological E Limited Overview
6.5.3 Biological E Limited Peptides Sales and Revenue in China Market (2016-2021)
6.5.4 Biological E Limited Peptides Product Description
6.5.5 Biological E Limited Recent Developments
6.6 Bharat Biotech
6.6.1 Bharat Biotech Corporation Information
6.6.2 Bharat Biotech Overview
6.6.3 Bharat Biotech Peptides Sales and Revenue in China Market (2016-2021)
6.6.4 Bharat Biotech Peptides Product Description
6.6.5 Bharat Biotech Recent Developments
6.7 Samarth Life Sciences Pvt. Ltd.
6.7.1 Samarth Life Sciences Pvt. Ltd. Corporation Information
6.7.2 Samarth Life Sciences Pvt. Ltd. Overview
6.7.3 Samarth Life Sciences Pvt. Ltd. Peptides Sales and Revenue in China Market (2016-2021)
6.7.4 Samarth Life Sciences Pvt. Ltd. Peptides Product Description
6.7.5 Samarth Life Sciences Pvt. Ltd. Recent Developments
6.8 VHB Life Sciences Limited
6.8.1 VHB Life Sciences Limited Corporation Information
6.8.2 VHB Life Sciences Limited Overview
6.8.3 VHB Life Sciences Limited Peptides Sales and Revenue in China Market (2016-2021)
6.8.4 VHB Life Sciences Limited Peptides Product Description
6.8.5 VHB Life Sciences Limited Recent Developments
6.9 Celon Laboratories Pvt. Ltd.
6.9.1 Celon Laboratories Pvt. Ltd. Corporation Information
6.9.2 Celon Laboratories Pvt. Ltd. Overview
6.9.3 Celon Laboratories Pvt. Ltd. Peptides Sales and Revenue in China Market (2016-2021)
6.9.4 Celon Laboratories Pvt. Ltd. Peptides Product Description
6.9.5 Celon Laboratories Pvt. Ltd. Recent Developments
6.10 United Biotech(P) Limited
6.10.1 United Biotech(P) Limited Corporation Information
6.10.2 United Biotech(P) Limited Overview
6.10.3 United Biotech(P) Limited Peptides Sales and Revenue in China Market (2016-2021)
6.10.4 United Biotech(P) Limited Peptides Product Description
6.10.5 United Biotech(P) Limited Recent Developments
7 China Peptides Production Capacity, Analysis
7.1 China Peptides Production Capacity, 2016-2027
7.2 Peptides Production Capacity of Key Manufacturers in China Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Peptides Supply Chain Analysis
9.1 Peptides Industry Value Chain
中國肽工業深入研究和趨勢預測報告2021-2027
9.2 Peptides Upstream Market
9.3 Peptides Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Peptides Distributors and Sales Agents in China Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of Tables
Table 1. Key Players of Peptides in China Market
Table 2. Top Peptides Players in China Market, Ranking by Revenue (2019)
Table 3. China Peptides Revenue by Companies, (US$, Mn), 2016-2021
Table 4. China Peptides Revenue Share by Companies, 2016-2021
Table 5. China Peptides Sales by Companies, (K Pcs), 2016-2021
Table 6. China Peptides Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Peptides Price (2016-2021) & (USD/Pcs)
Table 8. Manufacturers Peptides Product Type
Table 9. List of Tier 1 Peptides Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Peptides Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of Insulin
Table 12. Major Manufacturers of Teriparatide
Table 13. By Type – China Peptides Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - China Peptides Revenue (US$, Mn), 2016-2021
Table 15. By Type - China Peptides Revenue (US$, Mn), 2022-2027
Table 16. By Type - China Peptides Sales (K Pcs), 2016-2021
Table 17. By Type - China Peptides Sales (K Pcs), 2022-2027
Table 18. By Application – China Peptides Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - China Peptides Revenue (US$, Mn), 2016-2021
Table 20. By Application - China Peptides Revenue (US$, Mn), 2022-2027
Table 21. By Application - China Peptides Sales (K Pcs), 2016-2021
Table 22. By Application - China Peptides Sales (K Pcs), 2022-2027
Table 23. Cipla Ltd. Corporation Information
Table 24. Cipla Ltd. Description and Major Businesses
Table 25. Cipla Ltd. Peptides Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 26. Cipla Ltd. Peptides Product
Table 27. Cipla Ltd. Recent Developments
Table 28. Emcure Pharmaceuticals Pvt. Ltd. Corporation Information
Table 29. Emcure Pharmaceuticals Pvt. Ltd. Description and Major Businesses
Table 30. Emcure Pharmaceuticals Pvt. Ltd. Peptides Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 31. Emcure Pharmaceuticals Pvt. Ltd. Peptides Product
Table 32. Emcure Pharmaceuticals Pvt. Ltd. Recent Developments
Table 33. Gland Pharma Limited Corporation Information
Table 34. Gland Pharma Limited Description and Major Businesses
Table 35. Gland Pharma Limited Peptides Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 36. Gland Pharma Limited Peptides Product
Table 37. Gland Pharma Limited Recent Developments
Table 38. Troikaa Pharmaceuticals Ltd. Corporation Information
Table 39. Troikaa Pharmaceuticals Ltd. Description and Major Businesses
zhōngguó tài gōngyè shēnrù yánjiū hé qūshì yùcè bàogào 2021-2027
Table 40. Troikaa Pharmaceuticals Ltd. Peptides Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 41. Troikaa Pharmaceuticals Ltd. Peptides Product
Table 42. Troikaa Pharmaceuticals Ltd. Recent Developments
Table 43. Biological E Limited Corporation Information
Table 44. Biological E Limited Description and Major Businesses
Table 45. Biological E Limited Peptides Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 46. Biological E Limited Peptides Product
Table 47. Biological E Limited Recent Developments
Table 48. Bharat Biotech Corporation Information
Table 49. Bharat Biotech Description and Major Businesses
Table 50. Bharat Biotech Peptides Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 51. Bharat Biotech Peptides Product
Table 52. Bharat Biotech Recent Developments
Table 53. Samarth Life Sciences Pvt. Ltd. Corporation Information
Table 54. Samarth Life Sciences Pvt. Ltd. Description and Major Businesses
Table 55. Samarth Life Sciences Pvt. Ltd. Peptides Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 56. Samarth Life Sciences Pvt. Ltd. Peptides Product
Table 57. Samarth Life Sciences Pvt. Ltd. Recent Developments
Table 58. VHB Life Sciences Limited Corporation Information
Table 59. VHB Life Sciences Limited Description and Major Businesses
Table 60. VHB Life Sciences Limited Peptides Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 61. VHB Life Sciences Limited Peptides Product
Table 62. VHB Life Sciences Limited Recent Developments
Table 63. Celon Laboratories Pvt. Ltd. Corporation Information
Table 64. Celon Laboratories Pvt. Ltd. Description and Major Businesses
Table 65. Celon Laboratories Pvt. Ltd. Peptides Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 66. Celon Laboratories Pvt. Ltd. Peptides Product
Table 67. Celon Laboratories Pvt. Ltd. Recent Developments
Table 68. United Biotech(P) Limited Corporation Information
Table 69. United Biotech(P) Limited Description and Major Businesses
Table 70. United Biotech(P) Limited Peptides Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 71. United Biotech(P) Limited Peptides Product
Table 72. United Biotech(P) Limited Recent Developments
Table 73. Peptides Production Capacity (K Pcs) of Key Manufacturers in China Market, 2019-2021 (K Pcs)
Table 74. China Peptides Capacity Market Share of Key Manufacturers, 2019-2021
Table 75. Peptides Market Opportunities & Trends in China Market
Table 76. Peptides Market Drivers in China Market
Table 77. Peptides Market Restraints in China Market
Table 78. Peptides Raw Materials
Table 79. Peptides Raw Materials Suppliers in China Market
Table 80. Typical Peptides Downstream
Table 81. Peptides Downstream Clients in China Market
Table 82. Peptides Distributors and Sales Agents in China Market
List of Figures
Figure 1. Peptides Product Picture
Figure 2. Peptides Segment by Type
Figure 3. Peptides Segment by Application
Figure 4. China Peptides Market Overview: 2020
Figure 5. China Peptides Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. China Peptides Revenue, 2016-2027 (US$, Mn)
Figure 7. Peptides Sales in China Market: 2016-2027 (K Pcs)
中國ペプチド業界の深い研究動向予測レポート2021-2027
Figure 8. The Top 3 and 5 Players Market Share by Peptides Revenue in 2020
Figure 9. Insulin Product Picture
Figure 10. Teriparatide Product Picture
Figure 11. Liraglutide Product Picture
Figure 12. Leuprolide Product Picture
Figure 13. By Type - China Peptides Sales Market Share, 2016-2027
Figure 14. By Type - China Peptides Revenue Market Share, 2016-2027
Figure 15. By Type - China Peptides Price (USD/Pcs), 2016-2027
Figure 16. Diabetes
Figure 17. Infectious Diseases
Figure 18. Cancer
Figure 19. Osteoporosis
Figure 20. By Application - China Peptides Sales Market Share, 2016-2027
Figure 21. By Application - China Peptides Revenue Market Share, 2016-2027
Figure 22. By Application - China Peptides Price (USD/Pcs), 2016-2027
Figure 23. Cipla Ltd. Peptides Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. Emcure Pharmaceuticals Pvt. Ltd. Peptides Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. Gland Pharma Limited Peptides Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. Troikaa Pharmaceuticals Ltd. Peptides Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 27. Biological E Limited Peptides Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 28. Bharat Biotech Peptides Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 29. Samarth Life Sciences Pvt. Ltd. Peptides Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 30. VHB Life Sciences Limited Peptides Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 31. Celon Laboratories Pvt. Ltd. Peptides Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 32. United Biotech(P) Limited Peptides Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 33. China Peptides Production Capacity (K Pcs), 2016-2027
Figure 34. Peptides Industry Value Chain
Figure 35. Marketing Channels
……
請您致電：400 612 8668、010-6618 1099、66182099、66183099
或Email至：KF@Cir.cn 【網上訂購】 ┊ 下載《訂購協議》 ┊ 了解“訂購流程”
京公網安備 11010802027365號